Mounjaro Approval for Weight Loss: What the Evidence and Regulations Say
pharmaceutical-regulatory
Mounjaro (tirzepatide) is currently authorized in the United States and several other markets for adults with type 2 diabetes, and it is commonly prescribed to many people for w...
Open article